Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Targeted NO donor enhances the activity of aspirin and heparin in preventing embolization

June 8, 1998

Avigen and Cell Genesys report success with gene therapy of hemophilia B

June 2, 1998

Emisphere Technologies begins phase II trial with oral heparin

June 1, 1998

Integrilin launched in first market today

June 1, 1998

Schering AG presents factor Xa/thrombin inhibitors

June 1, 1998

New antiplatelet agents prepared by Sankyo/Ube researchers

May 29, 1998

P2T purinoceptor receptor antagonists with platelet antiaggregatory activity

May 28, 1998

First launch for Aggrastat, a new antiplatelet agent for acute coronary syndrome

May 26, 1998

FDA approves Aggrastat, the first platelet blocker for unstable angina

May 22, 1998

BLA and MAA filed for recombinant factor VIII product for hemophilia A

May 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...